REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,978 | -99.3% | 21,760 | +83.9% | 0.03% | +416.7% |
| Q3 2022 | $297,000 | -15.1% | 11,833 | +2.6% | 0.01% | -33.3% |
| Q2 2022 | $350,000 | -19.0% | 11,531 | -12.5% | 0.01% | -10.0% |
| Q1 2022 | $432,000 | +84.6% | 13,175 | +48.3% | 0.01% | +150.0% |
| Q4 2021 | $234,000 | -88.4% | 8,882 | -55.6% | 0.00% | -87.9% |
| Q3 2021 | $2,011,000 | -9.0% | 19,984 | +27.9% | 0.03% | -21.4% |
| Q2 2021 | $2,211,000 | +0.4% | 15,624 | -29.3% | 0.04% | -4.5% |
| Q1 2021 | $2,202,000 | +34.7% | 22,085 | +67.0% | 0.04% | -4.3% |
| Q4 2020 | $1,635,000 | +36.7% | 13,226 | +72.5% | 0.05% | -22.0% |
| Q2 2020 | $1,196,000 | +39.9% | 7,666 | +29.4% | 0.06% | -23.4% |
| Q1 2020 | $855,000 | -49.4% | 5,926 | -28.3% | 0.08% | +1.3% |
| Q4 2019 | $1,690,000 | – | 8,266 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |